{
    "2018-06-15": [
        [
            {
                "time": "2018-03-15",
                "original_text": "Moody's downgrades LifeScan Global's term loan B rating to B2 from B1",
                "features": {
                    "keywords": [
                        "downgrades",
                        "LifeScan",
                        "term loan",
                        "B2",
                        "B1"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-04-10",
                "original_text": "7 Perfect Dividend Stocks",
                "features": {
                    "keywords": [
                        "Perfect",
                        "Dividend",
                        "Stocks"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "all"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-05-20",
                "original_text": "10 Best Stocks to Buy and Hold Forever",
                "features": {
                    "keywords": [
                        "Best",
                        "Stocks",
                        "Buy",
                        "Hold",
                        "Forever"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "all"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-06-15",
                "original_text": "Can Investment Performance Be Predicted?",
                "features": {
                    "keywords": [
                        "Investment",
                        "Performance",
                        "Predicted"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "all"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-10",
                "original_text": "Glaxo Two-Drug HIV Combo Meets Primary Endpoint in Phase III",
                "features": {
                    "keywords": [
                        "Glaxo",
                        "Two-Drug",
                        "HIV",
                        "Combo",
                        "Phase III"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-08-20",
                "original_text": "Zacks Industry Outlook Highlights: Becton and Dickinson, Johnson & Johnson, Cigna and CVS Health",
                "features": {
                    "keywords": [
                        "Zacks",
                        "Industry",
                        "Outlook",
                        "Becton",
                        "Dickinson",
                        "Johnson & Johnson",
                        "Cigna",
                        "CVS Health"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-09-15",
                "original_text": "Dow 30 Stock Roundup: Caterpillar Raises Dividend, Merck's Keytruda Gets FDA Nod",
                "features": {
                    "keywords": [
                        "Dow 30",
                        "Caterpillar",
                        "Dividend",
                        "Merck",
                        "Keytruda",
                        "FDA"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "industrial",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-25",
                "original_text": "See what the IHS Markit Score report has to say about Johnson & Johnson.",
                "features": {
                    "keywords": [
                        "IHS Markit Score",
                        "report",
                        "Johnson & Johnson"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-11-10",
                "original_text": "Estimating The Fair Value Of Johnson & Johnson (NYSE:JNJ)",
                "features": {
                    "keywords": [
                        "Fair Value",
                        "Johnson & Johnson",
                        "NYSE:JNJ"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-12-05",
                "original_text": "Kyros Law is Investigating Claims on Behalf of Invokana users: 1,100 Invokana Lawsuits Alleging Diabetic Ketoacidosis, Kidney Injury, Amputations and Heart Complications Filed.",
                "features": {
                    "keywords": [
                        "Kyros Law",
                        "Invokana",
                        "Lawsuits",
                        "Diabetic Ketoacidosis",
                        "Kidney Injury",
                        "Amputations",
                        "Heart Complications"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-01-15",
                "original_text": "Growth & Income Buys | Johnson & Johnson and International Paper",
                "features": {
                    "keywords": [
                        "Growth",
                        "Income",
                        "Buys",
                        "Johnson & Johnson",
                        "International Paper"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "industrial"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}